299 related articles for article (PubMed ID: 16432293)
1. Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer.
Gencer M; Ceylan E; Aksoy N; Uzun K
Respiration; 2006; 73(4):520-4. PubMed ID: 16432293
[TBL] [Abstract][Full Text] [Related]
2. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
3. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
Li R; Li R; Wang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296
[TBL] [Abstract][Full Text] [Related]
4. Serum retinoic acid, retinol and retinyl palmitate levels in patients with lung cancer.
Moulas AN; Gerogianni IC; Papadopoulos D; Gourgoulianis KI
Respirology; 2006 Mar; 11(2):169-74. PubMed ID: 16548902
[TBL] [Abstract][Full Text] [Related]
5. Tissue polypeptide antigen in bronchogenic carcinoma.
Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
[TBL] [Abstract][Full Text] [Related]
6. Significance of serum sialoglycoproteins in patients with lung cancer.
Patel PS; Baxi BR; Balar DB
Neoplasma; 1989; 36(1):53-9. PubMed ID: 2539569
[TBL] [Abstract][Full Text] [Related]
7. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer].
Wu Y; Wu Y; Wang L; Qu L
Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921
[TBL] [Abstract][Full Text] [Related]
8. Plasma 7beta-hydroxycholesterol as a possible predictor of lung cancer risk.
Linseisen J; Wolfram G; Miller AB
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1630-7. PubMed ID: 12496054
[TBL] [Abstract][Full Text] [Related]
9. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulins and complement components in patients with lung cancer.
Oner F; Savaş I; Numanoğlu N
Tuberk Toraks; 2004; 52(1):19-23. PubMed ID: 15143368
[TBL] [Abstract][Full Text] [Related]
11. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.
Petridou ET; Mitsiades N; Gialamas S; Angelopoulos M; Skalkidou A; Dessypris N; Hsi A; Lazaris N; Polyzos A; Syrigos C; Brennan AM; Tseleni-Balafouta S; Mantzoros CS
Oncology; 2007; 73(3-4):261-9. PubMed ID: 18424891
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
13. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer.
Mizuguchi S; Inoue K; Iwata T; Nishida T; Izumi N; Tsukioka T; Nishiyama N; Uenishi T; Suehiro S
Ann Surg Oncol; 2006 Jul; 13(7):1010-8. PubMed ID: 16788764
[TBL] [Abstract][Full Text] [Related]
14. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
[TBL] [Abstract][Full Text] [Related]
15. Value of tumour and inflammatory markers in lung cancer.
Oremek GM; Sauer-Eppel H; Bruzdziak TH
Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
[TBL] [Abstract][Full Text] [Related]
16. High levels of oxidative stress in patients with advanced lung cancer.
Esme H; Cemek M; Sezer M; Saglam H; Demir A; Melek H; Unlu M
Respirology; 2008 Jan; 13(1):112-6. PubMed ID: 18197920
[TBL] [Abstract][Full Text] [Related]
17. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
[TBL] [Abstract][Full Text] [Related]
18. Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression.
Kanoh Y; Ohara T; Mashiko T; Abe T; Masuda N; Akahoshi T
Anticancer Res; 2006; 26(6B):4293-7. PubMed ID: 17201147
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of homocysteine as a cancer marker: total thiol compounds and folate levels in untreated lung cancer patients.
Ozkan Y; Yardim-Akaydin S; Firat H; Calişkan-Can E; Ardiç S; Simşek B
Anticancer Res; 2007; 27(2):1185-9. PubMed ID: 17465261
[TBL] [Abstract][Full Text] [Related]
20. Serum endostatin levels in patients with lung carcinoma.
Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
